HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion.

Abstract
We investigated the effect of different ACE inhibitors on tissue injury in isolated rat hearts subjected to 30 minutes of ischemia followed by 120 minutes of reperfusion. Zofenoprilat (1-100 microM), but not enalaprilat or lisinopril, significantly reduced infarct size, as estimated on the basis of triphenyltetrazolium chloride staining. The protection was not reproduced by the angiotensin II receptor antagonist irbesartan, and it was partly abolished by the bradykinin receptor antagonist HOE 140. Zofenoprilat molecule contains a sulfhydryl group, and its administration, as compared with enalaprilat or lisinopril administration, was associated with better preservation of protein thiols at the end of ischemia. We conclude that zofenopril has a specific cardioprotective effect, which might be related either to interference with bradykinin metabolism or to preservation of protein sulfhydryl groups.
AuthorsSabina Frascarelli, Sandra Ghelardoni, Simonetta Ronca-Testoni, Riccardo Zucchi
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 43 Issue 2 Pg. 294-9 (Feb 2004) ISSN: 0160-2446 [Print] United States
PMID14716220 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • zofenopril
  • Captopril
Topics
  • Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
  • Animals
  • Captopril (analogs & derivatives, therapeutic use)
  • Heart Rate (drug effects)
  • Male
  • Myocardial Ischemia (prevention & control)
  • Myocardial Reperfusion Injury (prevention & control)
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: